Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. - Wikidata - awgldk - TriplyDB

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

http://www.wikidata.org/entity/Q53620715

about

Human NKG2D-ligands: cell biology strategies to ensure immune recognition Regulation of immune cell function and differentiation by the NKG2D receptor An approach to the immunophenotypic features of circulating CD4⁺NKG2D⁺ T cells in invasive cervical carcinoma.An six-amino acid motif in the alpha3 domain of MICA is the cancer therapeutic target to inhibit shedding Cellular expression, trafficking, and function of two isoforms of human ULBP5/RAET1G.Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.NK1.1- CD4+ NKG2D+ T cells suppress DSS-induced colitis in mice through production of TGF-β N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.Regulation of ligands for the NKG2D activating receptor.Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.The selenium metabolite methylselenol regulates the expression of ligands that trigger immune activation through the lymphocyte receptor NKG2D Oncogenic stress sensed by the immune system: role of natural killer cell receptors Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells.CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation.NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system.Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status.MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.Activation and self-tolerance of natural killer cells.The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies Human natural killer cells.Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.Immunobiology and conflicting roles of the human NKG2D lymphocyte receptor and its ligands in cancer.Substantial increase in the frequency of circulating CD4+NKG2D+ T cells in patients with cervical intraepithelial neoplasia grade 1.Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus NK cells and cancer immunosurveillance.NKG2D ligands in tumor immunity.Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Human fused NKG2D-IL-15 protein controls xenografted human gastric cancer through the recruitment and activation of NK cells.Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.Cancer immunoediting of the NK group 2D ligand H60a.The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases.Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction.MICA-129Met/Val Polymorphism Is Associated with Early-Onset Breast Cancer Risk.Peginterferon Alfa-2a/Ribavirin treatment efficacy in chronic hepatitis C patients is related to natural killer group 2D gene rs1049174 GC polymorphism.

P2860

Q21131219-DD81F661-67EA-4701-812E-CEE62E371D4B Q24635093-97363719-1FB9-4BC3-AE5C-8758771D42E6 Q30400692-6893837C-8045-4B63-92C4-4BF188E9E33B Q30489974-7F569AD7-4147-4FBA-869E-FA8A95685D4A Q33410094-5759F59D-94F6-4457-9A2B-A524A37826FA Q33676231-C476C629-8AA3-449B-9A71-412AB15CF40E Q33844629-999B05DB-404F-4DE7-8795-66930B49A451 Q33931165-8B1400C2-9B14-48D3-AACA-BEBD0F9829D1 Q33999130-D319D5EE-2376-45B1-9AEB-510056232DEA Q34294166-21B7DE89-14D9-4EC5-A0A7-14E35F2423CB Q34321457-6715BAA7-FFBA-48B9-BAA0-026070EE34B4 Q34368956-53EAB7D9-FFFC-483F-B134-B1F05FF81A21 Q34467682-938DDD6F-50A3-4137-9412-4347617EDBA5 Q34473267-289F5801-92D6-40EF-B707-00F5507F5443 Q34652549-58F3A6BF-B9CC-4C5E-8A7F-0E46B8E8FE8B Q35055326-0B59E738-D2D7-494E-BAC9-2C8AFC3A2457 Q35562281-E371EDFC-097C-4B8B-A0C1-C600A2B1297F Q36060273-99954F4B-B849-406D-9E8A-D920A03779E6 Q36446189-6F8E954E-3FF9-4536-855B-3A05B539B426 Q36652183-3AC4C39B-5935-4702-BB1B-A0A076B162EC Q36685376-C6C100D8-F614-4B98-824C-CD549C3BF6E2 Q36787596-827CE7AF-0078-414E-A03B-A9B36E60D3A1 Q36810264-2C428F95-5BF6-4095-A930-17DEA7CF0DA5 Q37077413-788FFB2C-B25E-4B28-A7E5-E6F8F00FA090 Q37116995-C1D4831A-53BD-4E3B-970D-9709535E6F2D Q37273292-4BB31E99-8113-4D76-B118-AE40CF9D56A2 Q37287176-D3EA1CA8-7C5D-4264-AD98-CBEB2ADABF93 Q37287179-11EB69F4-9472-486B-A643-2B4959013EF2 Q37559284-0DB3E97D-F361-4676-B25D-7D68B61B4309 Q37667998-55D770C6-8EED-459C-AC01-4168A3C9EB95 Q37714638-9EB3B6BE-4223-47CC-B4C3-508DAF35C9BB Q37876089-3703C38C-0159-4C79-8C92-B43AD1AAF393 Q38223419-2F07BDFB-574E-4642-B511-5085A00D327D Q38257969-5788573A-93D8-48B1-B7E6-5A1F80CD21F3 Q38546761-CB7C58F9-3ECC-45E9-AAC1-81057ED45A5C Q38685657-6C5E8155-0C16-4E23-8192-931EE0A1231C Q39176227-BD04AA34-C133-4263-BF90-5E40CC861FF9 Q39537390-A4B9AFA1-F827-493C-AE52-EBB9873A4D89 Q40109211-276C08A7-62EE-4324-A3F1-EFEBFF41DA81 Q40399586-845D81A0-3BB5-40B2-B0EB-98FEE3FD9609

P2860

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

http://www.wikidata.org/entity/Q53620715

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@en

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@nl

type

label

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@en

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@nl

prefLabel

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@en

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@nl

P1433

Q53620715-FE40540D-AF42-43C4-9B48-790E8D823750

P1476

Q53620715-D7B4F240-CA7E-4425-B3CE-BDE098666E44

P2093

Q53620715-157A0B27-EC6E-4E90-B89C-21DE653A775F

Q53620715-3D6A0AB8-B986-4969-8AEF-DFD761F80D20

Q53620715-925697D3-F553-4EAE-BC64-0054EF01F92F

Q53620715-CEE9DFBF-6FBC-486B-8ADB-2D43CA584B09

P2860

Q53620715-0154AB6C-5023-4869-BAF6-9AA4DEA67B81

Q53620715-02D4164C-52B3-4897-A348-690C99B2952A

Q53620715-03CAA0D6-003D-4719-8AE8-F8CA75759945

Q53620715-15FD09CA-D9C9-457B-8980-D68E9FDD1D5C

Q53620715-1E4B91A2-A429-4F41-A5B7-9370E1D5F076

Q53620715-238208E7-EAC3-4C0F-A989-7B823831AEBC

Q53620715-343057EF-9ED1-4B25-81B3-0A444248262E

Q53620715-35E24F38-CAAB-49D9-95AF-7A626953F7BB

Q53620715-39476763-0522-462D-BD2E-9B8055387B97

Q53620715-3D4E201C-EEB9-4E85-98FE-0B3E80CB8921

P304

Q53620715-64696E93-C7F0-44B4-975C-CC40E05218F6

P31

Q53620715-76F01FD7-3610-4F7A-9274-3049519D69B3

P356

Q53620715-4068513C-4F38-457B-853C-1E14EDC1F4AE

P407

Q53620715-A3F3BB1A-B26B-422A-AE66-BF71A5636047

P433

Q53620715-614568A8-5768-4A39-A56F-3A7E8235D1A6

P478

Q53620715-19DF1365-6092-4C30-8F12-0E389D50807F

P577

Q53620715-CB28578A-74E4-4870-A36C-B223A0521515

P5875

Q53620715-6CA08D07-D429-4A4A-875C-EFE5A8570D41

P698

Q53620715-956373EE-706A-46AD-A195-70ED5F67698D

P356

P1433

Nature Immunology

P1476

Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity.

@en

P2093

Kimberly Smythe

http://www.w3.org/2001/XMLSchema#string

Thomas Spies

http://www.w3.org/2001/XMLSchema#string

Veronika Groh

http://www.w3.org/2001/XMLSchema#string

Zhenpeng Dai

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

An activating immunoreceptor complex formed by NKG2D and DAP10

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family

A Structural basis for the association of DAP12 with mouse, but not human, NKG2D

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors

The B7 family revisited

P304

755-762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NI1350

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7051087

http://www.w3.org/2001/XMLSchema#string

P698

16732291

http://www.w3.org/2001/XMLSchema#string